141 related articles for article (PubMed ID: 6690067)
1. Aminoglutethimide and warfarin. A new important drug interaction.
Lønning PE; Kvinnsland S; Jahren G
Cancer Chemother Pharmacol; 1984; 12(1):10-2. PubMed ID: 6690067
[TBL] [Abstract][Full Text] [Related]
2. Aminoglutethimide enzyme induction: pharmacological and endocrinological implications.
Lønning PE
Cancer Chemother Pharmacol; 1990; 26(4):241-4. PubMed ID: 2369789
[TBL] [Abstract][Full Text] [Related]
3. Effect of aminoglutethimide on antipyrine, theophylline, and digitoxin disposition in breast cancer.
Lønning E; Kvinnsland S; Bakke OM
Clin Pharmacol Ther; 1984 Dec; 36(6):796-802. PubMed ID: 6499359
[TBL] [Abstract][Full Text] [Related]
4. The influence of a graded dose schedule of aminoglutethimide on the disposition of the optical enantiomers of warfarin in patients with breast cancer.
Lønning PE; Ueland PM; Kvinnsland S
Cancer Chemother Pharmacol; 1986; 17(2):177-81. PubMed ID: 3719899
[TBL] [Abstract][Full Text] [Related]
5. Aminoglutethimide as an inducer of microsomal enzymes. Part 1: Pharmacological aspects.
Kvinssland S; Lønning PE; Ueland PM
Breast Cancer Res Treat; 1986; 7 Suppl():S73-6. PubMed ID: 2943339
[No Abstract] [Full Text] [Related]
6. Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer.
Lønning PE; Kvinnsland S
Drugs; 1988 Jun; 35(6):685-710. PubMed ID: 3048976
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen and aminoglutethimide in the management of patients with advanced endometrial carcinoma not responsive to medroxyprogesterone.
Quinn MA; Campbell JJ; Murray R; Pepperell RJ
Aust N Z J Obstet Gynaecol; 1981 Nov; 21(4):226-9. PubMed ID: 6951563
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of aminoglutethimide in humans: quantification and clinical relevance of induced metabolism.
Goss PE; Jarman M; Griggs LJ
Br J Cancer; 1985 Feb; 51(2):259-62. PubMed ID: 3838134
[TBL] [Abstract][Full Text] [Related]
9. Interaction of ascorbic acid and warfarin.
Smith EC; Skalski RJ; Johnson GC; Rossi GV
JAMA; 1972 Sep; 221(10):1166. PubMed ID: 4679014
[No Abstract] [Full Text] [Related]
10. Enoxacin-warfarin interaction: pharmacokinetic and stereochemical aspects.
Toon S; Hopkins KJ; Garstang FM; Aarons L; Sedman A; Rowland M
Clin Pharmacol Ther; 1987 Jul; 42(1):33-41. PubMed ID: 3474093
[TBL] [Abstract][Full Text] [Related]
11. Decreased serum concentrations of tamoxifen and its metabolites induced by aminoglutethimide.
Lien EA; Anker G; Lønning PE; Solheim E; Ueland PM
Cancer Res; 1990 Sep; 50(18):5851-7. PubMed ID: 2393854
[TBL] [Abstract][Full Text] [Related]
12. A review of enzyme induction of warfarin metabolism with recommendations for patient management.
Cropp JS; Bussey HI
Pharmacotherapy; 1997; 17(5):917-28. PubMed ID: 9324181
[TBL] [Abstract][Full Text] [Related]
13. Observations on the pharmacokinetics of low dose aminoglutethimide in patients with advanced breast cancer.
Stuart-Harris R; Bradbrook I; Morrison P; Smith IE; Rogers HJ
Br J Cancer; 1985 Apr; 51(4):485-92. PubMed ID: 3978028
[TBL] [Abstract][Full Text] [Related]
14. Biphasic sulphinpyrazone-warfarin interaction.
Nenci GG; Agnelli G; Berrettini M
Br Med J (Clin Res Ed); 1981 Apr; 282(6273):1361-2. PubMed ID: 6786498
[No Abstract] [Full Text] [Related]
15. Letter: Increased warfarin requirement during mercaptopurine therapy: a new drug interaction.
Spiers AS; Mibashan RS
Lancet; 1974 Jul; 2(7874):221-2. PubMed ID: 4135641
[No Abstract] [Full Text] [Related]
16. Aminoglutethimide in advanced breast cancer: plasma levels and clinical results after low and high doses.
Strocchi E; Camaggi CM; Martoni A; Cellerino R; Miseria S; Malacarne P; Indelli M; Balli M; Bonciarelli G; Ambroso G
Cancer Chemother Pharmacol; 1991; 27(6):451-5. PubMed ID: 2013115
[TBL] [Abstract][Full Text] [Related]
17. Induction of aromatase expression by aminoglutethimide, an aromatase inhibitor that is used to treat breast cancer in postmenopausal women.
Kao YC; Okubo T; Sun XZ; Chen S
Anticancer Res; 1999; 19(3A):2049-56. PubMed ID: 10470147
[TBL] [Abstract][Full Text] [Related]
18. Influence of aminoglutethimide on the metabolism of medroxyprogesterone acetate and megestrol acetate in postmenopausal patients with advanced breast cancer.
Lundgren S; Lønning PE; Aakvaag A; Kvinnsland S
Cancer Chemother Pharmacol; 1990; 27(2):101-5. PubMed ID: 2249324
[TBL] [Abstract][Full Text] [Related]
19. Multisite mucous membrane bleeding due to a possible interaction between warfarin and 5-fluorouracil.
Brown MC
Pharmacotherapy; 1997; 17(3):631-3. PubMed ID: 9165571
[TBL] [Abstract][Full Text] [Related]
20. Aminoglutethimide as an inducer of microsomal enzymes. Part 2: Endocrine aspects.
Lønning PE; Kvinnsland S; Thorsen T; Ekse D
Breast Cancer Res Treat; 1986; 7 Suppl():S77-82. PubMed ID: 3742065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
